15
staff
Jessica Marshall
Jessica Marshall is an associate at FasterCures.
staff
Margaret Anderson
Margaret is a Managing Director with Deloitte Consulting. She’s focused on bringing her experienc
e in research innovation and patient engagement to strengthen nonprofits, as well as federal and commercial life sciences programs.
+ Read More
staff
Shmuel Meitar
Shmuel Meitar is the founder of Time to Know, the first comprehensive digital teaching platform.
He established Time to Know in 2004 as a philanthropic endeavor in Israel and expanded it into an international business.
+ Read More
staff
Freda Lewis-Hall
During her 35-year career in medicine, Dr. Freda Lewis-Hall has been on the frontlines of health
care as a clinician, a researcher, and a leader in the biopharmaceuticals and life sciences industries.
+ Read More
staff
Freda Lewis-Hall
During her 35-year career in medicine, Dr. Freda Lewis-Hall has been on the frontlines of health
care as a clinician, a researcher, and a leader in the biopharmaceuticals and life sciences industries.
+ Read More
staff
Richard Merkin
Richard Merkin is the CEO and founder of the Heritage Group.
report
Policy Issue Brief: A Call to Action for Diversity in Clinical Trials
FasterCures has initiated a body of work to advance system change within biomedical research to foc
us on and value diversity and representation within clinical trials.
+ Read More
report
Expanding the Science of Patient Input: The Power of Language
Language matters.
report
Rx for Innovation: Recommendations for the New Administration
FasterCures wants President-elect Donald Trump to be ready to address biomedical innovation on day
one.
+ Read More
report
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to id
report
Landscape of Trust: Health Data Frameworks
The rapid advancement of the health technology landscape relies heavily on patient data.
video
Toward a Healthier Future
Conventional wisdom often suggests that a nation's health is a byproduct of its wealth.